Disease management and Patient monitoring

NEW

2023/03/09

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

This issue will be the last “Sleep and Sleep Tech” online roundtable discussion with clinical doctors, attended by doctors interested in the current focus on “sleep tech.”　The topic will evolve into implementing apps in the medical field, cognitive behavioral therapy, and more. 

LSMIP Editorial Office
NEW

2023/03/02

Utilization of Digital Technology in Mental Health and Psychiatry (Part 3)

Alcoholism and the Development of Therapeutic Apps

CureApp Inc.’s therapeutic app for alcohol dependence began clinical trials in Japan in January 2023. Dr. Amano focuses on the app and explains alcoholism and therapeutic apps from a psychiatrist’s perspective.

Nanao Amano
NEW

2023/02/22

Technology of Japanese start-up featured by doctors (Series ＃26）

Xenoma, Where Your Everyday Life Becomes Preventive Medicine

Xenoma Inc., a spin-off startup company from the University of Tokyo, provides “e-skin ECG”, the medical service to measure ambulatory ECG by wearing next-generation smart apparel. Dr. Shinpaku will explain the detail of "e-skin ECG".

Dr. Shinpaku
NEW

2023/02/16

Psychiatry and the Potential of Digital Tools（Series ＃5）

The Second Part: Brief Cognitive Function Assessment Scale in Middle Age and Beyond “The MCI Screen (Atama no Kenko Check)”

In the previous article, we provided an overview of “The MCI Screen (Atama no Kenko Check)” as a cognitive function scale is expected to detect mild cognitive impairment (MCI) at an early stage. In the second part of issue, Dr. Y, a psychiatrist, will explain the specifics of the system and examples of its use in clinical research.

Dr. Y

2023/02/01

Psychiatry and the Potential of Digital Tools（Series ＃4）

The First Part: Brief Cognitive Function Assessment Scale in Middle Age and Beyond “The MCI Screen (Atama no Kenko Check)”

It is said that “prevention” of dementia is the key to early detection and intervention to delay the onset of the disease. The “The MCI Screen (Atama no Kenko Check),” a cognitive function scale for healthy people with no complaints of cognitive decline, is expected to be useful for the early detection of mild cognitive impairment (MCI). Dr. Y, a psychiatrist, will explain this assessment scale in detail.

Dr. Y

2022/12/29

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 5】

Continuing from the previous meeting, doctors interested in “Sleep Tech” will gather to discuss “Sleep and Sleep Tech” frankly. This time, they will discuss topics such as smart rings and mindfulness.

LSMIP Editorial Office

2022/11/29

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 4】

Doctors interested in “Sleep Tech,” which has been the focus of much attention in recent years, were invited to gather to discuss “How does Sleep Tech work?” They will also talk about the effects and impressions of using it and ask each other about sleep-related topics. The content of this session is a casual read about “Sleep and Sleep Tech.” In this issue, we present the first of three roundtable discussions.

LSMIP Editorial Office

2022/11/17

Digital Health from a Healthcare Perspective (Part 9)

The Second Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

“Health2Sync,” provided by H2 Inc, a Taiwan-based health tech company, is the first application in Japan that can be linked to CGM data from Abbott Japan devices. Continuing from the first part, Dr. Amano, a diabetes specialist, will explain the details.

Natsu Ono M.D.

2022/11/10

Utilization of Digital Technology in Mental Health and Psychiatry (Part 2)

The Second Part: Apps and Wearable Devices in Sleep

Japan beginning in FY2022, the introduction of therapeutic apps in medicine is expected to gain momentum. Dr. Amano will discuss the expectations and challenges of introducing therapeutic apps for insomnia treatment from a psychiatrist's perspective.

Nanao Amano

2022/11/04

Digital Health from a Healthcare Perspective (Part 8)

The First Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

Health2Sync, which aims to support people's health with the “power of digital,” provides “Health2Sync,” a healthy lifestyle support application for self-management of chronic diseases such as diabetes, and “Health2Sync Platform,” a cloud service that enables medical institutions to view the data of the application. Ono M.D., a diabetes specialist, will explain these services.

Natsu Ono M.D.

2022/10/28

Utilization of Digital Technology in Mental Health and Psychiatry (Part 1)

The first part: Apps and Wearable Devices in Sleep

This is a new series in which Dr. Amano, a psychiatrist, and occupational health physician will explain the “Utilization of Digital Technology in Mental Health and Psychiatry” from her knowledge as a specialist. The content of this first issue is “The first part: Apps and Wearable Devices in Sleep.”

Nanao Amano

2021/09/24

Psychiatry and the Potential of Digital Tools（Series ＃3）

Current Status of Digital Therapeutics for Mild Cognitive Impairment

The number of patients with Alzheimer's disease (AD) is increasing, and digital therapeutics (DTx) for AD treatment is the focus of much attention. In the U.S., there are some startups that are supported by colossal research funds for research on screening for mild cognitive impairment (MCI). Dr. Y will explain the future of MCI treatment and DTx from the perspective of an active psychiatrist.

Dr. Y

2021/08/06

Psychiatry and the Potential of Digital Tools（Series ＃2）

Digital Screening for Cognitive Impairment

With the FDA approval of Aducanumab for the treatment of Alzheimer's disease, how will it affect future treatments? Dr. Y, a psychiatrist, explains his views on this issue, including expectations for digital therapeutics to identify mild cognitive impairment (MCI).

Dr. Y

2021/07/01

Technology of Japanese start-up featured by doctors (Series ＃3)

MEDITA (Formerly HERBIO) to conduct research and development on sensor-based body temperature fluctuations

MEDITA (formerly HERBIO), which has confirmed the correlation between temperature around the umbilical area and core body temperature, is conducting body temperature fluctuation research and analysis from data acquired by a wearable sensor under development. We will focus on the company's technology by a female CEO and CRO.

Dr. Shinpaku

2021/06/21

Psychiatry and the Potential of Digital Tools (Series #1)

The Impact of Changes in the COVID19 Pandemic on Psychiatry

Expectations for digital tools
In this new series of columns, an psychiatrist in Japan talks about the potential of digital tools in psychiatry. In this first part of a series, we present the expectations for digital tools for psychiatry in the COVID-19 Pandemic.

Dr. Y

Digital Health
U.S. eHealth Journal

Vol. 84 (Issued at 2023/３/14)

ジャーナル84号のトピックは、Aetion社 (RWE)、CytoReason社 (AI創薬)、Pear Therapeutics社 (PDTx)、Headspace Health社 (メンタルヘルスケア)、Tidepool (糖尿病ケア)、Akili Interactive社 (PDTx)、Amazon Pharmacy社 など

Most Popular

1位

Xenoma, Where Your Everyday Life Becomes Preventive Medicine

Dr. Shinpaku
2位

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

LSMIP Editorial Office
3位

Online Roundtable Discussion Among Clinical Doctors 【Part 5】

LSMIP Editorial Office
4位

Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Kazunori Seto M.D.
5位

LSMIP Editorial Office

Press Room

Placeholder